Clearstead Advisors, LLC - XORTX THERAPEUTICS INC ownership

XORTX THERAPEUTICS INC's ticker is and the CUSIP is 98420Q207. A total of 6 filers reported holding XORTX THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Clearstead Advisors, LLC ownership history of XORTX THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$3,000
+84.8%
5,000
+100.0%
0.00%
Q2 2023$1,623
+39.6%
2,5000.0%0.00%
Q1 2023$1,163
-42.4%
2,5000.0%0.00%
Q4 2022$2,020
-32.7%
2,5000.0%0.00%
Q3 2022$3,0002,5000.00%
Other shareholders
XORTX THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
ROYAL BANK OF CANADA 551$00.00%
OSAIC HOLDINGS, INC. 10,383$6,2270.00%
BANK OF AMERICA CORP /DE/ 2$10.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
TORONTO DOMINION BANK 53$2860.00%
Clearstead Advisors, LLC 5,000$3,0000.00%
View complete list of XORTX THERAPEUTICS INC shareholders